Legal Representation
Attorney
Max Vern
USPTO Deadlines
Next Deadline
705 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-10-16)
Due Date
October 16, 2027
Grace Period Ends
April 16, 2028
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 21, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jun 5, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 5, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jun 5, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 5, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 5, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 5, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Sep 15, 2023 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| May 3, 2018 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | Loading... |
| May 3, 2018 | 71AG | O | REGISTERED-SEC.71 ACCEPTED | Loading... |
| May 3, 2018 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Apr 16, 2018 | ES71 | I | TEAS SECTION 71 RECEIVED | Loading... |
| Oct 26, 2017 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Sep 8, 2017 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Apr 20, 2017 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Feb 9, 2017 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Feb 9, 2017 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Nov 3, 2016 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED | Loading... |
| May 12, 2014 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| May 12, 2014 | 71AG | O | REGISTERED-SEC.71 ACCEPTED | Loading... |
| May 12, 2014 | NA71 | O | NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED | Loading... |
| Apr 16, 2014 | 71AF | I | REGISTERED-SEC.71 FILED | Loading... |
| Apr 16, 2014 | ES71 | I | TEAS SECTION 71 RECEIVED | Loading... |
| Nov 11, 2011 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jul 15, 2010 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| May 15, 2009 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| May 8, 2008 | LIMN | I | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | Loading... |
| May 8, 2008 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Jan 28, 2008 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Jan 28, 2008 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jan 22, 2008 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Oct 16, 2007 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 27, 2007 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB | Loading... |
| Jul 31, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 11, 2007 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jun 26, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jun 25, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 24, 2007 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 31, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 31, 2007 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| May 31, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 31, 2007 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| May 14, 2007 | I | PAPER RECEIVED | Loading... | |
| May 9, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 9, 2007 | FAXX | I | FAX RECEIVED | Loading... |
| Mar 29, 2007 | RFNP | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 13, 2007 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 13, 2007 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 11, 2007 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 10, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Detailed Classifications
Class 001
Biochemicals, namely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases
Class 005
Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infections diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases
Class 042
Medical and scientific research, namely biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitation, namely, patent licensing; licensing of intellectual property in the field of medicine; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies
Classification
International Classes
001
005
042